0000950170-24-026055.txt : 20240305
0000950170-24-026055.hdr.sgml : 20240305
20240305163351
ACCESSION NUMBER: 0000950170-24-026055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HASTINGS PAUL J
CENTRAL INDEX KEY: 0001309702
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 24721212
MAIL ADDRESS:
STREET 1: 61 HARTFORD STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1150 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (925) 407-1049
MAIL ADDRESS:
STREET 1: 1150 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
ownership.xml
4
X0508
4
2024-03-01
0001787400
Nkarta, Inc.
NKTX
0001309702
HASTINGS PAUL J
C/O NKARTA, INC.
1150 VETERANS BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
true
true
false
false
Chief Executive Officer
false
Common Stock
2024-03-01
4
D
false
12358
13.00
D
378149
D
Common Stock
2024-03-04
4
D
false
137642
13.33
D
240507
D
The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and most recently amended on June 27, 2022.
This transaction was executed in multiple trades at prices ranging from $13.00 to $13.01. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $13.00 to $13.85. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Alicia Hager, as Attorney-in-Fact
2024-03-05